Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03991169 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Oral Iron in Children With Chronic Kidney Disease

Study acronym: FeTCh-CKD
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment target: 60 to 40
    • Primary and study completion dates: Dec 31, 2025 to Dec 31, 2028
    • Site details revised at 2 of 2 sites
    v8
  2. Primary and study completion dates: Dec 31, 2024 to Dec 31, 2025v7
  3. Primary and study completion dates: Dec 31, 2023 to Dec 31, 2024v6
  4. Primary and study completion dates: Dec 31, 2022 to Dec 31, 2023v5
  5. Enrollment target: 40 to 60
    • Primary and study completion dates: Dec 31, 2021 to Dec 31, 2022
    • Site contacts updated at 1 of 2 sites
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Site contacts updated at 1 of 2 sitesv3
  2. Site contacts updated at 1 of 2 sitesv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a pilot clinical trial of oral iron therapy in children with chronic kidney disease (CKD) and mild anemia. Eligible children will be randomized into a standard of care (iron sulfate) arm vs. no iron therapy arm for 3 months. The outcomes will include muscle strength, physical activity, and changes in eating behavior, which will be measured at enrollment and at the end of the study period.
Trial Details
NCT Number NCT03991169
Lead Sponsor Weill Medical College of Cornell University
Collaborators: Children's Hospital of Philadelphia
Conditions
(from sponsor)		 Chronic Kidney Insufficiency, Chronic Kidney Diseases
Related terms Anemia, Motor Activity, Renal Insufficiency, Chronic
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov